RRAS2 and triple-negative breast carcinoma: Indeed, targeted overexpression of human RRAS2 in mammary epithelial cells of genetically engineered mice provokes the development of triple-negative breast cancer in all female breeders, demonstrating a causal relationship between RRAS2 overexpression and postpartum-associated breast cancer.